Epidemiology of zoonotic hepatitis E: a community-based surveillance study in a rural population in China
Feng-Cai Zhu, Shou-Jie Huang, Ting Wu, Xue-Feng Zhang, Zhong-Ze Wang, Xing Ai, Qiang Yan, Chang-Lin Yang, Jia-Ping Cai, Han-Min Jiang, Yi-Jun Wang, Mun-Hon Ng, Jun Zhang, Ning-Shao Xia, Feng-Cai Zhu, Shou-Jie Huang, Ting Wu, Xue-Feng Zhang, Zhong-Ze Wang, Xing Ai, Qiang Yan, Chang-Lin Yang, Jia-Ping Cai, Han-Min Jiang, Yi-Jun Wang, Mun-Hon Ng, Jun Zhang, Ning-Shao Xia
Abstract
Background: Hepatitis E is caused by two viral genotype groups: human types and zoonotic types. Current understanding of the epidemiology of the zoonotic hepatitis E disease is founded largely on hospital-based studies.
Methods: The epidemiology of hepatitis E was investigated in a community-based surveillance study conducted over one year in a rural city in eastern China with a registered population of 400,162.
Results: The seroprevalence of hepatitis E in the cohort was 38%. The incidence of hepatitis E was 2.8/10,000 person-years. Totally 93.5% of the infections were attributed to genotype 4 and the rest, to genotype 1. Hepatitis E accounted for 28.4% (102/359) of the acute hepatitis cases and 68.9% (102/148) of the acute viral hepatitis cases in this area of China. The disease occurred sporadically with a higher prevalence during the cold season and in men, with the male-to-female ratio of 3∶1. Additionally, the incidence of hepatitis E increased with age. Hepatitis B virus carriers have an increased risk of contracting hepatitis E than the general population (OR = 2.5, 95%CI 1.5-4.2). Pre-existing immunity to hepatitis E lowered the risk (relative risk = 0.34, 95% CI 0.21-0.55) and reduced the severity of the disease.
Conclusions: Hepatitis E in the rural population of China is essentially that of a zoonosis due to the genotype 4 virus, the epidemiology of which is similar to that due to the other zoonotic genotype 3 virus.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Purcell RH, Emerson SU (2005) Prevention. In: Thomas HC, Lemon S, Zuckerman AJ, editors. Viral hepatitis, 3rd edn. Malden, MA Blackwell Publishing. pp. 635–645.
- Purcell RH, Emerson SU (2008) Hepatitis E: an emerging awareness of an old disease. J Hepatol 48: 494–503.
- Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S (2009) Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 361: 1025–1027.
- Teshale EH, Howard CM, Grytdal SP, Handzel TR, Barry V, et al. (2010) Hepatitis E epidemic, Uganda. Emerg Infect Dis 16: 126–129.
- Teshale EH, Hu DJ, Holmberg SD (2010) The two faces of hepatitis E virus. Clin Infect Dis 51: 328–334.
- Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R (2007) Locally acquired hepatitis E in chronic liver disease. Lancet 369: 1260.
- Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, et al. (2007) Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 46: 387–394.
- Lu L, Li C, Hagedorn CH (2006) Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 16: 5–36.
- Dalton HR, Bendall R, Ijaz S, Banks M (2008) Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 8: 698–709.
- Zhuang H, Zhu WF, Li F (1999) Studies on hepatitis E. . Chin Med Sci J 14: 47–50.
- Cooper K, Huang FF, Batista L, Rayo CD, Bezanilla JC, et al. (2005) Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations. J Clin Microbiol 43: 1684–1688.
- Corwin AL, Khiem HB, Clayson ET, Pham KS, Vo TT, et al. (1996) A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am J Trop Med Hyg 54: 559–562.
- Khuroo MS (1980) Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 68: 818–824.
- Naik SR, Aggarwal R, Salunke PN, Mehrotra NN (1992) A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 70: 597–604.
- Velazquez O, Stetler HC, Avila C, Ornelas G, Alvarez C, et al. (1990) Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987. JAMA 263: 3281–3285.
- Hoofnagle JH, Nelson KE, Purcell RH (2012) Hepatitis E. N Engl J Med 367: 1237–1244.
- Zheng Y, Ge S, Zhang J, Guo Q, Ng MH, et al. (2006) Swine as a Principal Reservoir of Hepatitis E Virus that Infects Humans in Eastern China. J Infect Dis 193: 1643–1649.
- Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, et al. (2005) Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 192: 1166–1172.
- Mansuy JM, Abravanel F, Miedouge M, Mengelle C, Merviel C, et al. (2009) Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 44: 74–77.
- Said B, Ijaz S, Kafatos G, Booth L, Thomas HL, et al. (2009) Hepatitis E outbreak on cruise ship. Emerg Infect Dis 15: 1738–1744.
- Dalton HR, Fellows HJ, Gane EJ, Wong P, Gerred S, et al. (2007) Hepatitis E in new zealand. J Gastroenterol Hepatol 22: 1236–1240.
- Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, et al. (2002) Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 40: 117–122.
- Abe K, Li TC, Ding X, Win KM, Shrestha PK, et al. (2006) International collaborative survey on epidemiology of hepatitis E virus in 11 countries. Southeast Asian J Trop Med Public Health 37: 90–95.
- Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, et al. (2009) Epidemiology of Hepatitis E Virus in the United States: Results from the Third National Health and Nutrition Examination Survey, 1988–1994. J Infect Dis 200: 48–56.
- Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, et al. (2011) Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17: 2309–2312.
- Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N (2007) Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 45: 2009–2010.
- Buti M, Dominguez A, Plans P, Jardi R, Schaper M, et al. (2006) Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 13: 1328–1332.
- Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, et al. (2009) Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 44: 272–276.
- Taniguchi M, Kim SR, Mishiro S, Takahashi K, Shin MH, et al. (2009) Epidemiology of hepatitis E in Northeastern China, South Korea and Japan. J Infect 58: 232–237.
- Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, et al. (2008) Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 47: 1026–1031.
- Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, et al. (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376: 895–902.
- Huang S, Zhang X, Jiang H, Yan Q, Ai X, et al. (2010) Profile of acute infectious markers in sporadic hepatitis E. PLoS One 5: e13560.
- Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, et al. (2006) Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 12: 1682–1688.
- Zhang J, Ge SX, Huang GY, Li SW, He ZQ, et al. (2003) Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J Med Virol 71: 518–526.
- Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al.. (2013) Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect. [Epub ahead of print]
- Wedemeyer H, Rybczynska J, Pischke S, Krawczynski K (2013) Immunopathogenesis of hepatitis E virus infection. Semin Liver Dis 33: 71–78.
- Seriwatana J, Shrestha MP, Scott RM, Tsarev SA, Vaughn DW, et al. (2002) Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol 9: 1072–1078.
- Myint KS, Endy TP, Gibbons RV, Laras K, Mammen MP Jr, et al. (2006) Evaluation of diagnostic assays for hepatitis E virus in outbreak settings. J Clin Microbiol 44: 1581–1583.
- Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP (2007) Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 14: 562–568.
- Legrand-Abravanel F, Thevenet I, Mansuy JM, Saune K, Vischi F, et al. (2009) Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 16: 772–774.
- Chen HY, Lu Y, Howard T, Anderson D, Fong PY, et al. (2005) Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis e virus in human sera. Clin Diagn Lab Immunol 12: 593–598.
- Myint KS, Guan M, Chen HY, Lu Y, Anderson D, et al. (2005) Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am J Trop Med Hyg 73: 942–946.
- Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, et al. (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358: 811–817.
Source: PubMed